Skip to main content

Cyren Reports Second Quarter 2020 Financial Results

Positive initial market traction with new strategy and enterprise offerings

McLEAN, VA / ACCESSWIRE / August 12, 2020 / Cyren (NASDAQ:CYRN), a provider of email security and threat intelligence solutions, today announced its second quarter 2020 financial results for the period ending June 30, 2020.

"During the second quarter Cyren continued to make good progress implementing our strategy. We achieved our key quarterly operational milestones, including completing the retooling of our U.S. salesforce, delivering two new enterprise products and closing our first customers for these new offerings" said Brett Jackson, Chief Executive Officer of Cyren. "With the key pieces of our foundational work behind us, we believe that we are positioned for bookings to accelerate in the second half as our new product sales execution matures and our first half pipeline building efforts begin to yield results".

Second Quarter 2020 Financial Highlights:

  • Revenues for the second quarter of 2020 were $9.2 million, compared to $9.7 million during the second quarter of 2019.
  • GAAP net loss for the second quarter of 2020 was $4.6 million, compared to a net loss of $4.6 million in the second quarter of 2019.
  • GAAP loss per basic and diluted share for the second quarter of 2020 was $0.08, compared to a loss of $0.08 per basic and diluted share for the second quarter of 2019.
  • Non-GAAP net loss for the second quarter of 2020 was $3.8 million, compared to a Non-GAAP net loss of $4.1 million for the second quarter of 2019.
  • Non-GAAP loss per basic and diluted share was $0.06 for the Q2 2020, compared to a Non-GAAP loss of $0.08 per share in Q2 2019.
  • Operating cash flow during the second quarter of 2020 was positive $2.5 million, compared to operating cash flow of positive $0.8 million during the second quarter of 2019.
  • Net cash flow for the second quarter of 2020 was positive $1.1 million, compared to negative $31 thousand during the second quarter of 2019.
  • Cash and cash equivalents balance as of June 30, 2020, was $16.1 million, compared to $11.6 million as of December 31, 2019.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Recent Business Highlights:

  • In April, Cyren launched a new cloud-based anti-phishing product targeted at enterprise customers using Microsoft 365 (formerly Office 365) email. Cyren Inbox Security (CIS) is fully integrated within Microsoft 365 and provides continuous email monitoring and threat detection with automated response and remediation.
  • Cyren recently announced positive early traction with Cyren Inbox Security and validating product market fit. In the first quarter of availability, Cyren converted several enterprise accounts and is protecting tens of thousands of Microsoft 365 mailboxes from phishing attacks, business email compromise (BEC) and fraudulent account takeovers.
  • Also during the second quarter, Cyren launched Threat InDepth, a threat intelligence data product that provides detailed and actionable intelligence to enterprise security teams. Threat InDepth leverages Cyren's GlobalView threat intelligence cloud, which analyzes billions of transactions daily to identify emerging security threats across email, web and files globally. Threat InDepth is the first product offering resulting from Cyren's strategy to expand its core threat intelligence services beyond the OEM market into the larger enterprise market.
  • In June, Cyren appointed a new Chairman of the Board, James Hamilton, who is an experienced security industry veteran. Mr. Hamilton was first appointed to the Cyren board of directors in 2012, and succeeds Lior Samuelson as Chairman.

Financial Results Conference Call:

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, August 12, 2020 to discuss second quarter results.

U.S. Dial-in Number: 1-877-407-0312
Israel Dial-in Number: 1-80-940-6247
International Dial-in Number: 1-201-389-0899

The call will be simultaneously webcast live on the investor relations section of Cyren's website at https://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20200812/en.

For those unable to participate in the live conference call, a replay will be available until August 26, 2020. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13707843. An archived version of the webcast will also be available on the investor relations section of the company's website at https://ir.cyren.com/events.

About Cyren:

More than 1.3 billion users around the world rely on Cyren's cloud security solutions to protect them against cyber attacks and data loss every day. Powered by GlobalView, Cyren's global security cloud that identifies emerging threats on a global basis in real-time, Cyren (NASDAQ: CYRN) delivers fast time-to-protection with embedded threat detection services, threat intelligence and enterprise email security products for leading email providers, cybersecurity vendors, service providers and enterprises. Learn more at www.cyren.com.

Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's publicly filed reports, which are available through www.sec.gov.

Company Contact
Mike Myshrall, CFO
Cyren

+1.703.760.3320
mike.myshrall@cyren.com

CYREN LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands of U.S. dollars, except per share amounts)

  Three months ended   Six months ended  
  June 30  June 30 
  2020  2019  2020  2019 
  Unaudited  Unaudited  Unaudited  Unaudited 
             
Revenues $9,181  $9,711  $18,830  $19,366 
                 
Cost of revenues  3,778   3,789   7,376   7,789 
                 
Gross profit  5,403   5,922   11,454   11,577 
                 
                 
Operating expenses:                
                 
Research and development, net  4,151   4,297   7,495   8,474 
                 
Sales and marketing  3,146   3,590   6,182   7,446 
                 
General and administrative  2,476   2,398   4,690   4,830 
                 
Total operating expenses  9,773   10,285   18,367   20,750 
                 
Operating loss  (4,370)  (4,363)  (6,913)  (9,173)
                 
Other income, net  2   17   8   265 
                 
Financial expenses, net  (290)  (268)  (521)  (321)
                 
Loss before taxes  (4,658)  (4,614)  (7,426)  (9,229)
                 
Tax benefit  44   41   61   80 
                 
Net loss $(4,614)  $(4,573)  $(7,365)  $(9,149) 
                 
                 
Loss per share - basic and diluted $(0.08) $(0.08) $(0.12) $(0.17)
                 
Weighted average number of shares outstanding:                
Basic and Diluted  60,041   54,424   59,862   54,300 
                 

CYREN LTD.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES

(in thousands of U.S. dollars, except per share amounts)

  Three months ended   Three months ended  
  June 30  June 30 
  2020  2019  2020  2019 
  Unaudited  Unaudited  Unaudited  Unaudited 
             
GAAP gross profit $5,403  $5,922  $11,454  $11,577 
GAAP gross margin  59%  61%  61%  60%
Plus:                
Stock-based compensation expense  20   33   64   62 
Amortization of intangible assets  593   767   1,024   1,606 
Non-GAAP gross profit  6,016   6,722   12,542   13,245 
Non-GAAP gross margin  66%  69%  67%  68%
                 
GAAP operating loss  (4,370)  (4,363)  (6,913)  (9,173)
Plus:                
Stock-based compensation expense  507   314   1,152   583 
Amortization of intangible assets  723   885   1,283   1,851 
Capitalization of technology  (389)  (650)  (1,602)  (1,392)
Settlement of litigation, net  -   -   -   - 
Non-GAAP operating loss  (3,529)  (3,814)  (6,081)  (8,131)
                 
GAAP net loss  (4,614)  (4,573)  (7,365)  (9,149)
Plus:                
Stock-based compensation expense  507   314   1,152   583 
Amortization of intangible assets  723   885   1,283   1,851 
Adjustment to earn-out liabilities  -   -   -   - 
Amortization of deferred tax assets  (48)  (58)  (96)  (115)
Gain from an earn-out liability settlement  -   -   -   (256)
Settlement of litigation, net  -   -   -   - 
Capitalization of technology  (414)  (688)  (1,657)  (1,458)
Non-GAAP net loss $(3,846) $(4,120) $(6,684) $(8,544)
                 
Numerator for non-GAAP EPS calculation $(3,846) $(4,120) $(6,684) $(8,544)
Non-GAAP net loss per share $(0.06) $(0.08) $(0.11) $(0.16)
                 
GAAP weighted-average shares used to                
compute net loss per share  60,041   54,424   59,862   54,300 
                 

CYREN LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars)

  June 30  December 31 
  2020  2019 
  Unaudited    
Assets      
Current Assets:      
Cash and cash equivalents $16,103  $11,551 
Trade receivables, net  2,366   2,187 
Deferred commissions  1,037   948 
Prepaid expenses and other receivables  1,203   819 
Total current assets  20,709   15,505 
         
Long-term deferred commissions  1,352   1,580 
Long-term lease deposits  850   767 
Operating lease right-of-use assets  11,466   8,695 
Severance pay fund  582   659 
Property and equipment, net  4,675   4,410 
Intangible assets, net  9,338   8,966 
Goodwill  20,251   20,246 
Total long-term assets  48,514   45,323 
Total assets $69,223  $60,828 
         
Liabilities and Shareholders' Equity        
Current Liabilities:        
Trade payables $1,106  $1,184 
Employees and payroll accruals  3,714   3,427 
Accrued expenses and other liabilities  1,200   1,145 
Operating lease liabilities  1,886   1,946 
Deferred revenues  9,714   7,208 
Total current liabilities  17,620   14,910 
         
Deferred revenues  1,460   1,956 
Convertible notes  10,000   10,000 
Convertible debentures  9,447   - 
Long-term operating lease liabilities  9,966   7,174 
Deferred tax liability  677   796 
Accrued severance pay  735   811 
Other liabilities  633   470 
Total long-term liabilities  32,918   21,207 
         
Shareholders' equity  18,685   24,711 
Total liabilities and shareholders' equity $69,223  $60,828 
         

CYREN LTD.
CONDENSED CONSOLIDATED CASH FLOW DATA

(in thousands of U.S. dollars)

   Three months ended     Six months ended  
   June 30    June 30 
   2020    2019    2020    2019 
Cash flows from operating activities:  Unaudited    Unaudited    Unaudited    Unaudited 
                    
Loss  (4,614)  (4,573)    (7,365)  (9,149)
                                
Adjustments to reconcile loss to net cash provided by (used in) operating activities:                               
Loss on disposal of property and equipment    26      -      13      1 
Depreciation    597      475      1,215      936 
Stock-based compensation    507      314      1,152      583 
Amortization of intangible assets    723      885      1,283      1,851 
Amortization of deferred commissions    452      (280)    803      (612)
Amortization of operating lease right-of-use assets    534      362      922      713 
Interest on convertible notes    142      142      283      282 
Interest and amortization of debt issuance costs on Convertible Debentures    187      -      211      - 
Other income related to the earn-out consideration    -      (1)    -      (257)
Deferred taxes, net    (54)    (58)    (118)    (127)
                                
Changes in assets and liabilities:                               
Trade receivables    490      27      (162)    705 
Prepaid expenses and other receivables    (57)    (37)    (383)    (775)
Deferred commissions    (276)    341      (664)    748 
Change in long-term lease deposits    28      3      (86)    23 
Trade payables    (159)    (418)    (114)    (823)
Employees and payroll accruals, accrued expenses and other liabilities    444      50      (47)    (224)
Deferred revenues    4,062      3,891      1,989      6,354 
Accrued severance pay, net    24      27      1      68 
Operating lease liabilities    (534)    (368)    (954)    (733)
Other long-term liabilities    10      -      163      (111)
Net cash provided by (used in) operating activities    2,532      782      (1,858)    (547)
                                
Cash flows from investing activities:                               
                                
Proceeds from sale of property and equipment    2      -      4      - 
Capitalization of technology    (588)    (808)    (1,589)    (1,435)
Purchase of property and equipment    (880)    (406)    (1,438)    (950)
Net cash used in investing activities    (1,466)    (1,214)    (3,023)    (2,385)
                                
Cash flows from financing activities:                               
                                
Proceeds from convertible debenture, net of debt issuance costs    -      -      9,442      - 
Payment of earn-out consideration    -      -      -      (2,680)
Proceeds from options exercised    -      323      -      512 
Net cash provided (used) by financing activities    -      323      9,442      (2,168)
Effect of exchange rate changes on cash    (7)    78      (13)    (48)
Increase (decrease) in cash, cash equivalents and restricted cash    1,059       (31)      4,548       (5,148) 
Cash, cash equivalents and restricted cash at the beginning of the period    15,616       13,039       12,127       18,156  
Cash, cash equivalents and restricted cash at the end of the period  16,675     13,008     16,675     13,008  
                                
Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow:                               
Cash and cash equivalents  16,103    12,405    16,103    12,405 
Restricted cash included in long-term restricted lease deposits    572      603      572      603 
                                
Total cash, cash equivalents and restricted cash  16,675     13,008     16,675     13,008  
                                

SOURCE: Cyren Ltd



View source version on accesswire.com:
https://www.accesswire.com/601257/Cyren-Reports-Second-Quarter-2020-Financial-Results

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.